Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial

Oliver Distler, Yannick Allanore, Christopher P. Denton, Masataka Kuwana, Marco Matucci‐Cerinic, Janet Pope, Tatsuya Atsumi, Radim Bečvář, László Czirják, É. Hachulla, Tomonori Ishii, Osamu Ishikawa, Sindhu R. Johnson, Ellen De Langhe, Chiara Stagnaro, Valeria Riccieri, Elena Schiopu, Richard M. Silver, Vanessa Smith, Virginia Steen, Wendy Stevens, Gabriella Szűcs, Marie‐Elise Truchetet, Melanie Wosnitza, Kaisa Laapas, Frank Krämer, Dinesh Khanna